Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Foghorn Therapeutics Inc
FHTXCurrent price
8.8 USD
-0.06 USD (-0.68%)
Last closed
8.85 USD
Company
foghorntx.com
ISIN
US3441741077
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
519 795 520 USD
Yield for 12 month
+119.45 %
1Y
3Y
5Y
10Y
15Y
FHTX
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It develops FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM that is in phase I for the treatment of relapsed and/or refractory acute myeloid leukemia/myelodysplastic syndrome. The company is also developing therapies for mutant cancers, such as Non-Small Cell Lung, bladder, endometrial, colorectal, and melanoma cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 500 Technology Square, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16 USDP/E ratio
–Dividend Yield
–Current Year
+34 155 000 USD
Last Year
+19 228 000 USD
Current Quarter
+7 808 000 USD
Last Quarter
+6 888 000 USD
Current Year
+25 494 000 USD
Last Year
+19 208 772 USD
Current Quarter
+7 108 000 USD
Last Quarter
+6 088 000 USD
Key Figures FHTX
1 year
3 years
5 years
10 years
EBITDA
-98 527 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.45 %
PEG Ratio
–
Return On Equity TTM
-470.38 %
Wall Street Target Price
16 USD
Revenue TTM
25 515 000 USD
Book Value
-0.51 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-55.3 %
Dividend Yield
–
Gross Profit TTM
-86 390 000 USD
Earnings per share
-1.85 USD
Diluted Eps TTM
-1.85 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics FHTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History FHTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation FHTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
11.4234
Price Sales TTM
20.3722
Enterprise Value EBITDA
-1.2144
Price Book MRQ
10.707
Financials FHTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators FHTX
For 52 weeks
2.7 USD
10.25 USD
50 Day MA
8.45 USD
Shares Short Prior Month
1 195 340
200 Day MA
6.63 USD
Short Ratio
6.83
Shares Short
1 326 842
Short Percent
3.18 %
BeatStart